Novartis names drugs chief as CEO to deliver return to growth
Joe Jimenez to retire in February after eight years at the helm
Joe Jimenez to retire in February after eight years at the helm
Emma Walmsley’s lack of experience cited as justification for salary
Company says that fourth-quarter core net income fell 5 per cent to $2.707bn
Currency fluctuations undermine CEO’s efforts to increase profitability
Income for core businesses climbed 9 per cent in the quarter to $3.65 billion
Transactions worth $140bn so far this year include asset swap between Novartis and GlaxoSmithKline
Bayer also preparing for potential auction of unit
Pharma firm will expand in faster-growing areas of healthcare
Crosswords & puzzles to keep you challenged and entertained
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices